ADVANCE Study: in patients with Type 2 diabetes mellitus, antihypertensive therapy decreases cardiovascular risk inde pendently of baseline blood pressure

ADVANCE Study: in patients with Type 2 diabetes mellitus, antihypertensive therapy decreases cardiovascular risk inde pendently of baseline blood pressure

Blood pressure (BP) level is an important determinant of micro- and macrovascular complication risk in patients with Type 2 diabetes mellitus (DM-2). One of the aims of ADVANCE Study was, therefore, to assess the effects of Fixed-dose perindopril and indapamide (Noliprel®) combination, added to stan...

Full description

Bibliographic Details
Main Author:	I. E. Chazova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	type 2 diabetes mellitus arterial hypertension cardiovascular complication risk advance study
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1265

Similar Items

Risk of cardiovascular complications in patients with frequent hypertensive crises
by: Igor' Petrovich Kolos, et al.
Published: (2009-09-01)

Antihypertensive therapy effectiveness in patients with arterial hypertension and varying risk of cardiovascular events
by: I. E. Chazova, et al.
Published: (2008-04-01)

ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS: AN INDIVIDUALIZED CHOICE OF ANTIHYPERTENSIVE MEDICATIONS
by: T. E. Morozova, et al.
Published: (2011-04-01)

Metabolic effects of antihypertensive medications: prognostic role in the development of cardiovascular disease and diabetes mellitus
by: M. V. Stroeva, et al.
Published: (2010-04-01)

EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS
by: O. A. Koshel'skaya, et al.
Published: (2015-12-01)

Combined antihypertensive treatment in hypertensive patients and type 2 diabetes mellitus
by: Yuriy Ivanovich Nestepov, et al.
Published: (2009-02-01)

Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension
by: Nihan Kahya Eren, et al.
Published: (2014-12-01)

Role of Adherence to Treatment in the Correction of the Risk of Cardiovascular Complications in Patients with Arterial Hypertension with Accompanying Diabetes Mellitus
by: O. Voloshyna, et al.
Published: (2024-09-01)

The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
by: Juliya V Zhernakova, et al.
Published: (2019-09-01)

Oxidative stress and metabolic parameters in hypertensive patients with/without diabetes mellitus in cardiovascular risk evaluation
by: Nemes-Nagy Enikő, et al.
Published: (2022-10-01)

New opportunities of antithrombotic therapy in patients with type 2 diabetes mellitus and stable coronary heart disease for reducing the cardiovascular risk and cardiovascular complications: THEMIS, THEMIS-PCI trials
by: Victor I. Kalashnikov, et al.
Published: (2022-11-01)

Clinical features of arterial hypertension in men and women (according to the National Registry of Arterial Hypertension)
by: I E Chazova, et al.
Published: (2019-01-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

PROLOG Study: decreasing cardiovascular disease risk in hypertensive patients by antihypertensive therapy
by: S. A. Shalnova, et al.
Published: (2005-08-01)

The incidence of cardiovascular and cerebrovascular complications in patients with uncontrolled hypertension
by: Anastasiya R. Denisova, et al.
Published: (2022-01-01)

Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
by: Olga Konstantinovna Vikulova
Published: (2012-06-01)

Antihypertensive therapy and diabetes mellitus incidence: is it possible to reduce the risk?
by: M. G. Glezer
Published: (2008-12-01)

Cardiovascular complications in COVID‐19 patients with or without diabetes mellitus
by: Temidayo Abe, et al.
Published: (2021-04-01)

Blood Pressure Target in Type 2 Diabetes Mellitus
by: Hyun-Jin Kim, et al.
Published: (2022-09-01)

Control of blood pressure and cardiovascular outcomes in type 2 diabetes
by: Vargas-Uricoechea Hernando, et al.
Published: (2018-08-01)

Therapeutic education of patients with Type 2 diabetes mellitus and high cardiovascular risk
by: E. A. Palferova, et al.
Published: (2007-12-01)

COEXISTANCE OF DIABETES MELLITUS AND THYROID DISORDERS: A VIEW ON DYSFUNCTION OF THE ENDOCRINE SYSTEM
by: Adu Albert Asare, et al.
Published: (2018-07-01)

Age‐Specific Associations Between Systolic Blood Pressure and Cardiovascular Disease: A 10‐Year Diabetes Mellitus Cohort Study
by: Eric Yuk Fai Wan, et al.
Published: (2020-07-01)

NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY
by: A. V. Rudenko, et al.
Published: (2015-09-01)

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2015-09-01)

Dynamics of endothelial function in patients with arterial hypertension with different cardiovascular risk against the background of antihypertensive therapy
by: N.O. Pertseva, et al.
Published: (2024-10-01)

Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort study
by: Hack-Lyoung Kim, et al.
Published: (2020-10-01)

Control of cardiovascular risk in patients with diabetes
by: Yu V Zhernakova, et al.
Published: (2016-09-01)

Control of cardiovascular risk in patients with diabetes
by: Zhernakova Yu.V., et al.
Published: (2016-08-01)

Antihypertensive therapy in men and women in real clinical practice according to the National register
by: E V Oshhepkova, et al.
Published: (2019-09-01)

Reduction in diastolic blood pressure and cardiovascular mortality in nondiabetic hypertensive patients. A reanalysis of the HOT study
by: Antonio Alberto Lopes, et al.
Published: (2001-08-01)

Hypertensive diabetic patients: incidence of cardiovascular and renal outcomes in a historical cohort over 11 years
by: Andréa Cristina Sousa, et al.
Published: (2017-12-01)

Pharmaceutical and non-pharmaceutical antihypertensive therapy in Type 2 diabetes mellitus patients
by: S. G. Malishevsky
Published: (2006-04-01)

Progress on the pathogenesis of cardiovascular complications in patients with type 2 diabetes mellitus
by: ZHENG Tian-sheng, TONG Xue-wei, ZHANG Yi-tong, ZHU Min, ZHAN Xiao-rong
Published: (2022-05-01)

Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies
by: Nawfal Hasan Siam, et al.
Published: (2024-12-01)

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension
by: Eirik Olsen, et al.
Published: (2021-03-01)

MICROCIRCULATION IN ARTERIAL HYPERTENSION: EFFECTS OF BLOOD PRESSURE CONTROL WITH ANTIHYPERTENSIVE THERAPY
by: A. A. Kirichenko, et al.
Published: (2012-06-01)

Factors associated with cardiovascular disease in patients with type 2 diabetes mellitus
by: Tan, Mun Chieng
Published: (2013)

THIRTY-TWO-YEAR DYNAMICS AND PROGNOSTIC SIGNIFICANCE OF BASELINE LEVELS OF SYSTEMIC PRESSURE IN TEENAGE BOYS
by: A. A. Aleksandrov, et al.
Published: (2017-10-01)

Risk of Stroke according to the Duration of Diabetes Mellitus with Hypertension
by: Hee Sung Kim
Published: (2020-09-01)